CNH Global’s fourth-quarter and full-year results, filed Thursday, reflected a continued decent agricultural equipment selling environment coupled with further construction…
Browsing: Scientific Instruments
Daimler missed the Street’s third-quarter earnings per share consensus of EUR 1.13 by EUR 0.08. Year-over-year margins continue to tighten…
Philips delivered a fourth-quarter loss of EUR 0.39 per share, EUR 0.22 larger than the loss in the fourth quarter…
Roche reported 2012 results that were roughly in line with our expectations, as the firm’s core EPS of CHF 13.62…
In its second quarter as a stand-alone company, Tyco reported respectable operating results, given the challenging macroeconomic environment. An intense…
STMicroelectronics reported decent fourth-quarter results and gave investors a predictably soft first-quarter outlook that was in line with analysts expectations.…
In Alstom’s third-quarter sales update, the company reported 1% year-over-year sales growth, while orders grew 3% over the same period.…
On Tuesday, February 11, Corporate Executive Board reported what we consider mixed fourth-quarter results. Adjusted EPS of $0.84 were $0.01 higher than our estimate but $0.01 below the consensus.
The long-awaited results of the review by Yale University of Medtronic’s Infuse bone morphogenic protein turned out to be disappointing.…
Mornginstar Research is maintaining their $21 fair value estimate for CBRE Group following the commercial real estate services firm’s acquisition…
Teva Pharmaceuticals announced a settlement with Pfizer PFE for its at-risk launch of Protonix in 2008. The $1.6 billion settlement…
Spectra Energy’s SE decision to accelerate asset dropdowns to its master limited partnership, Spectra Energy Partners SEP , should provide…